PHAXIAM Therapeutics S.A. Depreciation Expense
PHAXIAM Therapeutics S.A. reported Depreciation Expense of EUR 584.00 thousand for the 6-month period ending 2019-06-30, per its 6-K filed 2019-09-26.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:DepreciationExpense · last filed 2019-09-26
- 2019-06-30: Depreciation Expense 6 month 584.00K EUR.
| Period end | Depreciation Expense 6 month |
|---|---|
| 2019-06-30 | 584.00K EUR 6-K · filed 2019-09-26 |